Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
Home
Tags
Covid 19
Tag: covid 19
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
0
Ahead of Vaccine, Fast, Affordable Testing for COVID is Still Essential...
Paul Archie
-
December 10, 2020
0
Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a...
Innovation Pharmaceuticals
-
June 17, 2020
0
Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial of ATI-450 for Cytokine Release...
Aclaris Therapeutics, Inc.
-
June 17, 2020
0
- Advertisement -
LATEST NEWS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Aclaris Therapeutics, Inc.
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Aclaris Therapeutics, Inc.
-
February 22, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Aclaris Therapeutics, Inc.
-
December 22, 2020
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva...
Aclaris Therapeutics, Inc.
-
December 8, 2020
LATEST INTERVIEWS
